Search results
Cologuard is intended to screen adults 45 and older at average risk for colon cancer. In a study of 10,000 people of average risk, Cologuard found 92% of cancer. Cologuard was negative in 87% of patients without cancer.
Backed by strong science and robust clinical research in collaboration with Mayo Clinic, Cologuard® is a stool DNA-based colorectal cancer screening test for average-risk individuals who are 45 or older.
May 15, 2023 · Cologuard is a non-invasive test for colon cancer that you can perform in the comfort of your own home. It checks for evidence of cancer in a small sample of stool (poop) that you mail to a lab. Cologuard is less accurate than a colonoscopy —the preferred method of screening—and is not a replacement for that test.
Nov 8, 2022 · 3 min read. Testing yourself for colon cancer is now easier and more accurate. Cologuard is a do-it-yourself kit that allows you to collect your stool sample in the privacy of your home. The FDA...
Jun 26, 2023 · Cologuard is an at-home prescription stool DNA test for colorectal cancer screening. It detects specific DNA alterations and blood abnormalities in the stool that may indicate the presence of...
Definition. Cologuard is a screening test for colon and rectal cancer. The colon sheds cells from its lining every day. These cells pass with the stool through the colon. Colon cancer cells may have DNA changes in certain genes. Cologuard detects the altered DNA.
Cologuard® is intended for the qualitative detection of colorectal neoplasia associated DNA markers and for the presence of occult hemoglobin in human stool. A positive result may indicate the presence of colorectal cancer (CRC) or advanced adenoma (AA) and should be followed by diagnostic colonoscopy.
